Background-The endothelium of healthy aortic valves expresses different phenotypes on the aortic and ventricular sides.
D egenerative aortic valve disease is the most common cause of valvular heart disease and accounts for most of the 95,000 valve procedures in the United States each year. 1 Aortic valve sclerosis (AVS), which marks the first step in degenerative aortic valve disease, is present in more than 25% of people older than 65 years and in more than 50% of people older than 85 years. 2 The pathology ranges from diffuse thickening to focal areas of calcific sclerosis, which can progress to valve stenosis and compromised valvular function. Recent research 3, 4 has shown AVS to be a complex and active inflammatory process. The pathogenesis is side specific and occurs preferentially on the aortic side of the valve leaflets. The histology and composition of advanced lesions have been well characterized, but early AVS and the mechanisms that lead to lesion initiation and progression have received little attention. A better understanding of these early processes is crucial to finding either preventative options or therapeutic alternatives to valve replacement surgery.
AVS and arterial atherosclerosis share common systemic risk factors (ie, hypercholesterolemia [HC], smoking, hypertension, and male sex) and also an important local risk factor (ie, flow disturbance) through which endothelial phenotype is linked to pathogenesis. 5, 6 Endothelial dysfunction is a hallmark of arterial atherosclerosis and regulates many of the key processes integral to disease initiation and progression. 7 However, the role of the endothelium in valvular disease is not understood. 4 There are few molecular studies of valve endothelium in situ. In vitro studies have shown that porcine aortic valve endothelial cells have distinct gene expression profiles compared with their arterial counterparts 8 ; furthermore, they may influence valvular interstitial cell phenotypes in coculture. 9 In vivo studies have mostly focused on endothelial signaling pathways during valve development. 10 Early studies 11, 12 of valve development identified morphological differences between the aortic and ventricular side endothelial cells and showed that hemodynamics played a role in patterning these differences. More recently, the endothelial cells on the aortic and ventricular sides of healthy swine aortic valve leaflets ( Figure 1A ) were shown to have distinct phenotypic profiles. 6 On the aortic side endothelium of the leaflet, which is susceptible to calcific sclerosis, there was differential expression of genes that promote skeletal development and vascular calcification. Despite its procalcific phenotype, however, the aortic side endothelium of healthy valves also expressed compensatory protective mechanisms, including an antiinflammatory gene profile. Similar coexisting balances have been noted in endothelium located in atherosclerosissusceptible regions of large arteries. 5, 13 The coexistence of susceptible and protective endothelial phenotypes in the healthy valve suggests a tenuous balance that preserves functional homeostasis and inhibits pathological processes. Herein, we report the use of a modest systemic insult (2-week HC) in a swine model of early aortic valve disease to shift the existing equilibrium toward early pathology and to determine if there is side-specific differential sensitivity. A 2-week exposure was sufficient to affect both gene and protein phenotypic changes, but brief enough to capture the transition from healthy tissue to early pathology. A broad genomics-based approach, coupled with sidespecific spatial resolution to probe endothelial populations, is necessary to begin to understand such a complex and multifactorial process. We found that the aortic side endothelium is markedly more sensitive to HC than the ventricular side endothelium, specifically upregulating protective pathways, including a peroxisome proliferator-activated receptor (PPAR) ␥-mediated program. Immunohistochemistry evidence suggests that these changes may be sustained at the protein level after 6 months of HC.
Methods
Supplemental materials can be found at: http://www.ahajournals.org. Briefly, aortic valves were harvested from mature castrated domestic male swine randomly assigned to a standard corn/soybean diet or an isocaloric diet high in fat (12.0%) and cholesterol (1.5%) for either 2 weeks or 6 months. Tissue from both the 2-week and 6-month cohorts was processed for histology and immunohistochemistry using standard techniques, and endothelium from the 2-week HC valves was processed for transcript profiling.
Endothelial cell RNA isolation procedures and bioinformatics are described in the supplemental materials, and the genomic data are publicly available at ArrayExpress (Study ID: CBIL-47).
Results

Side-Specific Early Pathological Changes in a Swine Model of Early AVS
Initial signs of pathological change appeared on the aortic side of valve leaflets after 2 weeks of HC. Discrete regions of extracellular subendothelial lipid insudation and occasional early calcific nodules were restricted to the aortic side of the leaflet ( Figure 1B, supplement 1A) . In contrast, no histological changes were observed on the ventricular side. CD11b/ MAC1 and HAM 56 staining was negative (not shown), indicating the absence of macrophage and foam cell accumulation in areas of lipid deposition. These observations are consistent with evidence that lipoprotein particles associate with the extracellular matrix to form liposomes in the valve interstitium, often considered the first event in AVS, 14 and indicate a shift from healthy (but susceptible) tissue toward early pathology. Thus, in a swine model, modest HC for a limited period induced side-specific pathological changes consistent with those of early human AVS.
A longer exposure to HC (6 months) produced similar, but more extensive, pathology, including an increase in the number and size of regions of lipid insudation ( Figure 1C ) and calcification ( Figure Supplement 1B) restricted to the aortic side. In particular, there was greater extracellular lipid deposition and evidence of intracellular lipid deposition, but frank inflammation was not noted (see supplemental materials).
The side-specific endothelial responses that accompanied the initiation of early AVS (2 weeks) were investigated using broad gene expression analyses. Specifically, the susceptible aortic and protected ventricular side endothelia of aortic valve leaflets of both normocholesterolemia (NC) and HC male swine were profiled by microarray analysis. Four transcript profile comparisons were conducted to analyze the effect of HC in the context of valve sidedness. First, to confirm previous findings, a paired comparison of the aortic side endothelium to the ventricular side endothelium was conducted in NC swine. Second, we separately examined the effects of HC on each side of the valve. Finally, a paired comparison of the aortic side endothelium with the ventricular side endothelium was conducted in HC swine.
Side-Specific Endothelial Cell Phenotypes in NC
In agreement with previous findings, 6 many genes were differentially expressed between the aortic and ventricular side endothelial cells of aortic valve leaflets from healthy swine (see supplemental materials).
Heightened Sensitivity of Aortic Side Endothelium to HC
To investigate endothelial responses in early AVS, cells from each side of the valve leaflets were separately profiled in NC and HC swine. Each NC animal was randomly paired with an HC animal, and the aortic side endothelium of each NC animal was compared directly with the aortic side endothelium of an HC animal. Similarly, the ventricular side endothelium of each NC animal was compared directly with the ventricular side endothelium of an HC animal. The aortic side endothelium was markedly more responsive to HC than the ventricular side endothelium. As shown in the Table, HC induced the differential expression of 1,325 genes on the aortic side of the leaflet when compared with the NC state. In contrast, only 87 genes were differentially expressed by HC on the ventricular side.
Pathway Analyses of HC-Induced Differential Gene Expression in Aortic Side Endothelium Indicate Pathoprotective Responses
The response of the aortic side endothelium to HC was examined using ingenuity pathway analysis, as described in the supporting materials. The 1,325 genes differentially expressed by HC on the aortic side were examined for top-scoring networks, overrepresented canonical pathways, and functional categories. These analyses, in the context of the current AVS literature, identified a concise list of key differentially expressed genes ( Figure 2 ). Ingenuity pathway analysis then identified relationships between the genes based on either direct molecular or protein binding or indirect transcriptional or regulatory effects. Genes known to play a role in AVS pathology and genes involved in cellular proliferation, molecular transport, and lipid trafficking were differ-entially expressed and highly interconnected ( Figure 2 ). A cluster of caspase 3 (CASP3)-related genes was differentially expressed. These include downregulation of bone morphogenic protein 4 (BMP4) in HC animals; BMP4 is an inflammatory mediator in endothelial cells capable of inducing intercellular adhesion molecule expression. 15, 16 BMP4 may play a role in aortic valve calcification 17 and can also increase expression of cysteine-rich angiogenic inducer 61, 18 which can, in turn, increase CASP3 activation. 19 The downregulation of both genes is consistent with a decrease in CASP3 activation. Similarly, increases in glutathione peroxidases 1 and 4 (GPX1 and GPX4, respectively), potent antioxidants that were upregulated in the HC animals, can decrease CASP3 activation. 20, 21 A decrease in BMP4 expression and CASP3 activation indicates a protective antiapoptotic phenotype. 22 Both upstream regulators and downstream targets of PPAR-␥ were differentially expressed ( Figure 2 ). Nuclear receptor corepressor 2, a PPAR-␥ repressor, was downregulated; and PPAR-␥ activator nuclear receptor coactivator 1 was upregulated. In the absence of ligand, PPAR-␥ recruits nuclear receptor corepresser 2, decreasing the transcription factor activity. 23 Conversely, nuclear receptor coactivator 1 increases PPAR-␥ transcriptional activity. 24 Several direct downstream targets of PPAR-␥ that are highly relevant to aortic valve pathology and cholesterol transport were the most highly upregulated genes in the HC animals. These included fatty acid binding protein 1 (FABP1), which binds certain lipids and long-chain fatty acids and may be involved in their intracellular trafficking. 25 PPAR-␥ has a complex relationship with FABP-1. It is known to bind FABP-1 promoter and increase transcription of the gene, 26 but there is also evidence that FABP-1 may act as a PPAR-␥ ligand to regulate PPAR-␥ activation. 27 PPAR-␥ is reported to increase expression of ATP-binding cassette A1, 28 which was also highly upregulated in the HC animals. Furthermore, PPAR-␥ has been shown to act on macrophages to decrease production of inflammatory mediator and increase oxidized low-density lipoprotein scavenger receptor in a lipid accumulation positive feedback loop. 29 PPAR-␥ is an upstream regulator of osteopontin, which was the most highly upregulated gene and is known to have a protective anticalcific effect in the valve. 30 The direction of differential expression of these genes is consistent with the induction of a protective PPAR-␥ phenotype in early AVS. Several other gene pathways, including annexin A2 (ANXA2) and transforming growth factor-␤1 clusters, were differentially expressed in a similar manner, consistent with a protective phenotype (see supplemental materials).
In contrast, gene expression in the ventricular side endothelium was largely uninfluenced by HC, with only 87 nonspecific genes differentially expressed (see supplemental materials).
Paired Aortic Side to Ventricular Side Comparisons of Endothelial Gene Expression in HC Corroborates a Protective Aortic Side Response
After examining the effect of HC on the aortic and ventricular side endothelium separately, as previously described, paired comparisons of the aortic and ventricular side phenotypes within each HC animal were conducted. Pathway analysis of 1,638 genes differentially expressed (895 upregulated and 743 downregulated) between the aortic and ventricular sides of HC animals identified TNF-␣-centric pathways as the top-scoring network. HC downregulated TNF-␣ on the aortic side and induced the differential expression of genes known to interact with TNF-␣, either directly at the protein level or through a transcriptional effect ( Figure 3A) . For example, the patterns of expression of squalene epoxidase, TNF-␣ inhibitor protein 3-interacting protein 2, and cytosolic phospholipase A2 and its regulators were consistent with a protective phenotype on the aortic side (see supplemental materials).
In addition to ingenuity pathway analysis/network analysis, canonical pathway analysis of the genes differentially expressed between the aortic and ventricular sides in HC animals was performed ( Figure 3B ). G-protein-coupled receptor signaling, which includes nuclear factor (NF)-B-and mitogen-activated protein kinase-related genes, was identified as the most overrepresented canonical pathway. Inflam-matory mediators RelA and TNF-␣ were downregulated and NF-B inhibitors IA and IB were upregulated on the aortic side, suggesting a shift toward an anti-inflammatory state on the aortic side endothelium. RelA is the predominant and most active NF-B species in endothelial cells and is inhibited by I-Ba and I-Bb. 31 In summary, both the network and canonical pathway analyses suggest enhanced anti-inflammatory and antiapoptosis profiles on the AVS-susceptible aortic side relative to the ventricular side, consistent with the induction of a protective endothelium during HC. Osteopontin also emerged from this analysis as the most highly differentially expressed gene, corroborating the protective phenotype on the aortic side relative to the ventricular side in HC animals.
In Situ Protein Expression of Aortic Valve Endothelium
The spatial distribution of protein products was examined by immunohistochemistry ( Figure 4 and Figure 5 ). After 2 Figure 4 . Side-specific expression of endothelial proteins in aortic valves exposed to hypercholesterolemia (HC) for 2 weeks. A, Peroxisome proliferator-activated receptor (PPAR)-␥ expression was heterogeneous and confined to the aortic side endothelium. B, Fatty acid binding protein 1 (FABP1) was expressed in aortic side endothelial cells in a heterogeneous distribution. weeks of HC, the endothelium expressed increased amounts of PPAR-␥. Expression was confined to the aortic side and was often localized in endothelial nuclei, suggesting PPAR-␥ activation ( Figure 4A ). FABP1, a target of PPAR-␥, was similarly expressed (adjacent section, Figure 4B ). Both PPAR-␥ and FABP1 expression was heterogeneous within the aortic side.
Healthy swine expressed minimal amounts of PPAR-␥ in the endothelium ( Figure 5 ). Immunohistochemistry of the aortic side after 2 weeks of HC, however, showed endothelial expression to be greatly enhanced; expression persisted at 6 months ( Figure 5) . Similarly, the direct downstream targets of PPAR-␥, including ATP-binding cassette A1 and FABP1, were minimally expressed in healthy swine aortic valves. However, as with PPAR-␥, there was a clear increase in protein expression after 2 weeks of HC, which persisted at 6 months. These findings are consistent with an HC-induced activation of a PPAR-␥-mediated program that begins in the earliest stages of AVS.
Discussion
To examine the complex and multifactorial processes in early AVS in vivo, we combined a broad genomics-based approach with precise spatial resolution in a large animal model. To our knowledge, the present study is the first to examine the valve endothelium in the earliest stages of AVS and to identify a spatial shift of phenotype balance in response to a brief systemic insult. We found that the aortic side endothelium is much more responsive to HC than the adjacent ventricular side endothelium, and unexpectedly expressed overall protective pathways on the side vulnerable to AVS.
Differential endothelial responses to HC were identified using four different genomewide comparisons: two within-animal comparisons, in which the aortic and ventricular sides were compared; and two between-animal comparisons, in which the effect of HC on a single side of the valve was considered. These single-side analyses between NC and HC swine provided insight about the within-animal comparisons. For example, the finding that TNF-␣ and NF-B genes were downregulated on the aortic side relative to the ventricular side in HC animals could be interpreted as a proinflammatory profile on the ventricular side rather than an antiinflammatory profile on the aortic side. Furthermore, the between-animal genomic analyses were not sufficiently sensitive to identify TNF-␣ differences between NC and HC groups on either the aortic or the ventricular side. However, because the effect of HC on the ventricular side phenotype was minimal, the relative differences can be interpreted as a protective anti-inflammatory profile on the aortic side.
Furthermore, the four different genomic comparisons have inherently different sensitivities. Although the within-animal comparisons eliminated interanimal variability and were, therefore, more sensitive, the direct comparison of the aortic side endothelium in healthy swine to the aortic side endothelium in HC swine probed the phenotypes associated with pathological changes. For example, the within-animal comparisons revealed the downregulation of TNF-␣ and NF-B pathways on the aortic side, whereas the between-animal comparisons showed that HC induced several protective mechanisms, including upregulating GPX1 and GPX4 expression and activating a PPAR-␥-mediated pathway. Both analyses also identified osteopontin as the most responsive gene in early AVS. Osteopontin has been shown to inhibit and promote regression of calcification in aortic valves in vivo, suggesting a further protective mechanism. 30 These phenotype changes, identified by two independent analyses, are consistent with the upregulation of protective pathways by HC on the AVS-susceptible aortic side and represent the earliest endothelial response in AVS.
Macromolecular transport studies in the aortic valve have shown that lipid can cross the endothelium focally, causing discrete lesions, as seen in Figure 1 ; and passively, possibly at sites of apoptotic endothelial cells. 32 Once in the subendothelial space, lipid can form liposomes and can associate with the extracellular matrix to create a propathological environment for underlying valvular interstitial cells. The endothelium may upregulate protective pathways, such as PPAR-␥, to protect the valve from the systemic insult. PPAR-␥ has been shown to have broad protective endothelial effects, including reduced endothelial activation and inflammation. 33 The upregulation of downstream targets FABP1 and adenosine 5Ͻ Ͻ-triphosphatebinding cassette A1, involved in lipid trafficking and the cholesterol efflux pathway, marks a second mechanism of protection. Furthermore, PPAR-␥ interacts with cytokines and NF-B to suppress inflammatory processes in endothelial cells. 34 Despite recent interest and ongoing investigations into the role of the PPAR-␥ pathway in vascular disease and atherosclerosis, the role of PPAR-␥ agonists (eg, rosiglitazone or pioglitazone) in valvular disease has not been explored and may prove highly relevant to AVS pathogenesis. Although dietary and interanimal variability in the withinanimal comparisons was controlled by directly comparing aortic with ventricular side endothelial cells, there was significant phenotypic heterogeneity between sides of the aortic valve leaflets in both NC and HC swine. Both aortic and ventricular sides of the valve endothelium derive from a common lineage 10 ; therefore, differences in endothelial phenotype between the two populations of endothelial cells are an adaptive response to the local environment, which is characterized by prominent differences in surface hemodynamics and tissue biomechanics. 35 The effect of hemodynamics on endothelial cell phenotype has been studied extensively in the arterial endothelium. Unidirectional laminar flow with high average shear stress (undisturbed flow) is atheroprotective, whereas laminar and turbulent multidirectional flow containing low average shear stress (disturbed flow) is atheropermissive. 36 The healthy aortic valve functions in a complex flow environment in which the ventricular side is exposed to undisturbed flow throughout the cardiac cycle in contrast to the aortic side endothelium, which is exposed to highly disturbed flow throughout most of the cycle. 35 These differences may be critical in establishing not only endothelial phenotype heterogeneity but also differential endothelial responsiveness to a systemic insult, such as HC.
The analyses presented herein lead to a potentially important question that cannot be fully resolved in the present experiments: why does AVS appear and progress on the aortic side despite the expression of protective endothelial pathways? It is unclear if the endothelial phenotype switches from a predominantly protective phenotype to an atheropermissive phenotype or if the endothelium continues to express protective pathways throughout AVS pathogenesis. The protective phenotype changes may be an adaptive (defensive) response to the altered lipid environment to retain normal functioning of the endothelium. There is no evidence of inflammatory mediation by the endothelium (as appears to occur in atherogenesis) at either 2 weeks (no aortic and ventricular side differential transcript expression of adhesion molecules) or 6 months (no obvious differences in adhesion molecule expression by immunohistochemistry).
Is it possible that the aortic side susceptibility is independent of the endothelium? This possibility would need to accommodate the distinct phenotypic differences between the aortic and ventricular side in NC 6 and the compelling data in this article showing much greater sensitivity of the aortic side to HC when analyzed in two fundamentally different ways. However, it is conceivable that these effects are unrelated to the spatial localization of AVS. At 6 months, the practical difficulty of dealing with lesion heterogeneity within a leaflet side requires a more sensitive genomic analysis, including selection and isolation of endothelium from histological sections by laser capture microscopy to phenotype endothelial cells overlying discrete lesions. Such genomic analyses are feasible and necessary to further define the phenotype heterogeneity, possibly link it to hemodynamic biomechanics, and lead to a better spatiotemporal understanding of the molecular changes in valvular endothelial cells that underlie AVS.
